Exstent to sponsor London Aorta 2022

Exstent Ltd is sponsoring London Aorta 2022, which runs 29 – 30 September 2022 at the Royal College of Physicians. The purpose of the event is to foster and encourage a multidisciplinary approach to aortic diseases which are often complex and require life-long surveillance.

For more information, visit www.londonaorta.org.

We hope to see you there.

PEARS features in two presentations at the AATS Aortic Symposium Workshop Boston

PEARS was featured in two presentations given at the American Association for Thoracic Surgery’s Aortic Symposium Workshop Boston, which took place in Boston on 13 and 14 May 2022.

Lukas Van Hoof’s presentation was ‘Personalised External Aortic Root Support and Valve Sparing Root Replacement in Syndromic Aortic Root Aneurysm: A Propensity Score-Matched Analysis’. Read more about the presentation.

Ana Redondo’s presentation was ‘Personalised External Aortic Root Support (PEARS): Our Preliminary Single Surgeon Results on 100 Patients’. Read more about the presentation.

Full information on the symposium, which focused on the pathophysiology, diagnosis, and treatment of aortic aneurysms and dissections, is available on the AATS website.

Tal Golesworthy to speak at Manufacturing Chemist Live

Tal Golesworthy will be speaking at Manufacturing Chemist Live, which runs 25-26 May 2022 at the National Conference Centre in Birmingham.

The event is designed to highlight the current standards and regulations affecting the pharmaceutical industry and latest production protocols. It will shine a spotlight on reducing the complexity, cost and risk of successful drug delivery, by exploring the drug supply chain through live lectures, seminars and panel discussions.

Tal’s presentation will be ‘Innovation in medicine: patient, heal thyself!’

For more information about the conference and to book tickets, visit the Manufacturing Chemist Live website.

Tal Golesworthy to give Keynote at HL7 FHIR DevDays International 2022

On 7 June 2022, Tal Golesworthy will present a keynote at HL7® FHIR® DevDays International 2022 in Cleveland, Ohio, USA.

In ‘Patient data: enabling personalised surgery’, Tal will argue that patients with appropriate technical and professional skills can contribute to medical development  and change patient treatments and outcomes IF they are granted access to and taken seriously by the world of medicine. Tal’s journey through the PEARS project illustrates what can be achieved if clinicians’ minds are opened to new ways of processing patient data.

Fast Healthcare Interoperability Resources (FHIR) is the global industry standard for passing healthcare data between systems and the DevDays International provides a plethora of content for both developers and non-coders, for FHIR starters and FHIR experts alike.

For more information, visit the HL7® FHIR® DevDays International 2022 website.